• home
• about us
  • the advantage
  • key facts
  • where we are
  • where we invest
  • management team
  • funds
• portfolio
  • companies
  • CEOs
• news
• investments
  • focus
    • prevention & nutraceuticals
    • medical foods OTC, Rx
    • enabling technologies
    • brands & channels
    • diagnostics
  • criteria
  • process
• your business
• careers
• contact us
  • the bahamas
  • united kingdom
  • switzerland
  • new zealand

portfolio

CEOs

Thomas Warthoe, Atonomics

"Atonomics' vision and Inventages' early investment emphasize our common belief that new and improved technology can and will impact positively quality of life for most people. Today's paradigm shift in how the measurement of biomarkers are used in a personalized medicine context - and recently even how biomarkers are used to maximize the advantage of nutritional health foods - makes Inventages' early investment into technology that facilitates on-the-spot biomarker testing very relevant."

About Atonomics...

Back to CEOs ...